352 material Form 8-K filings that 310 companies we cover made with the SEC in August 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Primerica reported second-quarter 2024 GAAP net income of $1.2 million, or $0.03 per diluted share, down from $144.5 million a year earlier. The drop reflects $253.6 million in goodwill and other long-lived asset impairments tied to the company's exit from the Senior Health business, and the company says it excluded these items from its adjusted results, where adjusted operating earnings per diluted share rose 18% to $4.71.
GAAP diluted EPS was $0.03 versus $3.97 a year earlier; net income was $1.2 million versus $144.5 million.
Total revenues rose 17% to $803.4 million, including $50 million in insurance claim proceeds; adjusted operating revenues rose 9% to $753.3 million.
Adjusted operating EPS was $4.71, up from $3.99; adjusted net operating income rose 12% to $162.7 million.
The Board approved a 20% dividend increase to $0.90 per share, payable September 12, 2024; the company repurchased $142.7 million of common stock in the quarter.
Envista reported second-quarter 2024 sales of $633.1 million, down from $662.4 million a year earlier, and a net loss of $1,151.6 million, or $6.69 per share, driven by a $1,153.8 million non-cash goodwill and intangible asset impairment. Adjusted EPS fell to $0.11 from $0.43, and the company guided to a 1% to 4% core sales decline for full-year 2024, with a further decline expected in the third quarter.
Q2 sales were $633.1 million, down from $662.4 million; core sales declined 3.2%.
Net loss was $1,151.6 million, or $6.69 per share, including a $1,153.8 million non-cash impairment charge.
Adjusted EPS was $0.11 versus $0.43; adjusted EBITDA was $63.0 million versus $126.2 million.
For 2024, the company expects core sales to decline 1% to 4% and adjusted EBITDA margins of 10% to 12%.
ICU Medical reported second quarter 2024 revenue of $596.5 million, up from $549.3 million a year earlier, but its GAAP net loss widened to $21.4 million, or $0.88 per share, from $9.9 million, or $0.41 per share. The company also narrowed its full-year 2024 guidance, raising the low end of its adjusted diluted EPS range to $4.95 from $4.40, which shareholders will weigh against lower second quarter adjusted EPS of $1.56 versus $1.88.
Second quarter revenue was $596.5 million versus $549.3 million; GAAP gross margin was 35% in both periods.
Adjusted diluted EPS was $1.56 versus $1.88, and adjusted EBITDA was $91.3 million versus $98.1 million.
FY2024 adjusted EBITDA guidance narrowed to $345 million to $365 million from $330 million to $370 million.
FY2024 adjusted diluted EPS guidance updated to $4.95 to $5.35 from $4.40 to $5.10; GAAP net loss guidance narrowed to $(118) million to $(108) million.
Maximus reported fiscal third-quarter 2024 revenue of $1.31 billion, up 10.6% from a year earlier, and diluted earnings per share of $1.46 versus $0.50. The company raised its fiscal 2024 guidance for a third consecutive time, with adjusted diluted EPS now expected at $6.00 to $6.20, which points to stronger earnings for shareholders.
Q3 FY2024 revenue rose 10.6% to $1.31 billion; diluted EPS was $1.46 versus $0.50 a year earlier
Adjusted diluted EPS was $1.74 versus $0.78 in the prior-year quarter
FY2024 guidance: revenue $5.25 billion to $5.35 billion; adjusted diluted EPS $6.00 to $6.20; free cash flow $350 million to $380 million
Quarterly dividend of $0.30 per share is payable August 31, 2024
Texas Pacific Land reported second-quarter 2024 net income of $114.6 million, or $4.98 per diluted share, and consolidated revenues of $172.3 million, with the water services and operations segment posting record results. The company also set a target cash balance of about $700 million and said it will direct most free cash flow above that level to share repurchases and dividends, which bears directly on how shareholders receive cash.
Q2 2024 net income was $114.6 million ($4.98 diluted per share), compared with $114.4 million in Q1 2024.
Consolidated revenues were $172.3 million, down from $174.1 million in Q1 2024.
Water segment: water sales of $40.7 million, produced water royalties of $25.3 million, and segment net income of $34.5 million.
Target cash balance of about $700 million; a $10.00 special dividend was declared and paid on July 15, 2024.
Dolby reported fiscal third-quarter 2024 revenue of $288.8 million, down from $298.4 million a year earlier, while GAAP net income rose to $38.4 million, or $0.40 per diluted share, from $16.4 million, or $0.17. The company also declared a $0.30 per share dividend and raised its stock repurchase authorization by $350 million to about $422 million, and gave full-year fiscal 2024 revenue guidance of $1.27 billion to $1.29 billion.
Total revenue was $288.8 million, versus $298.4 million in the third quarter of fiscal 2023.
GAAP net income was $38.4 million, or $0.40 per diluted share; non-GAAP net income was $68.8 million, or $0.71 per diluted share.
Full-year fiscal 2024 revenue is expected to range from $1.27 billion to $1.29 billion, with GAAP diluted EPS of $2.40 to $2.55.
Dividend of $0.30 per share is payable August 27, 2024, to holders of record on August 19, 2024.
Dutch Bros reported second-quarter 2024 results on August 7, 2024, with total revenue up 30.0% year over year and net income rising to $22.2 million from $9.7 million. The company raised its 2024 revenue and Adjusted EBITDA guidance and lowered its capital expenditure range, which indicates higher expected operating results for shareholders.
Total revenues were $324.9 million, up 30.0% from $249.9 million a year earlier.
Net income was $22.2 million, or $0.12 per diluted share, versus $9.7 million, or $0.05, in Q2 2023.
2024 total revenue guidance was raised to $1.215 billion to $1.230 billion, from $1.20 billion to $1.215 billion.
2024 Adjusted EBITDA guidance was raised to $200 million to $210 million, from $195 million to $205 million.
Boot Barn reported first-quarter fiscal 2025 net sales up 10.3% to $423.4 million and diluted EPS of $1.26, up from $1.13 a year earlier. The company also replaced its prior fiscal 2025 guidance, raising the expected diluted EPS range to $5.05 to $5.35 from a prior high end of $4.85, which signals higher expected profit for shareholders.
Q1 net sales rose 10.3% to $423.4 million; consolidated same store sales rose 1.4%, with e-commerce up 6.7%.
Q1 net income was $38.9 million, or $1.26 per diluted share, versus $34.3 million, or $1.13, a year earlier, including a benefit of about $0.06 per share from share-based compensation tax accounting.
Fiscal 2025 net sales guidance is $1.816 billion to $1.850 billion, versus a prior high end of $1.800 billion; income from operations guidance is $207.0 million to $219.4 million.
Second-quarter guidance calls for total sales of $405 million to $412 million and diluted EPS of $0.81 to $0.87.
Sabra Health Care REIT reported second-quarter 2024 net income of $0.10 per diluted share, up from $0.09 a year earlier, and raised its 2024 earnings guidance ranges. The company also declared a quarterly dividend of $0.30 per share, which matters to shareholders because it reflects both higher reported earnings and the updated outlook.
Q2 2024 net income was $0.10 per diluted share versus $0.09 in Q2 2023; FFO was $0.35 versus $0.32
2024 guidance raised: net income $0.48-$0.51, Normalized FFO $1.36-$1.39, Normalized AFFO $1.41-$1.44 per diluted share
Quarterly dividend of $0.30 per share declared August 7, 2024, payable August 30, 2024 to holders of record on August 19, 2024
Net Debt to Adjusted EBITDA was 5.45x as of June 30, 2024; liquidity was approximately $906.0 million
Sunstone Hotel Investors reported second quarter 2024 net income of $26.1 million, down from $43.1 million a year earlier, and income per diluted share of $0.11 versus $0.19. The company cut its full-year 2024 net income guidance to $55 million to $65 million from $56 million to $77 million, citing a slower recovery in Maui, which lowers the revenue and earnings outlook for shareholders.
Q2 2024 net income was $26.1 million versus $43.1 million; comparable RevPAR fell 2.0% to $232.59.
Full-year 2024 net income guidance is now $55 million to $65 million, down from $56 million to $77 million; total portfolio RevPAR growth guidance is now -0.25% to +1.75%, down from +2.25% to +5.25%.
Adjusted FFO per diluted share was $0.28 in Q2 2024, down 15.2%; full-year guidance is $0.85 to $0.90 versus $0.84 to $0.94 previously.
Through August 6, 2024, the company repurchased 698,043 shares at an average $9.90; $447.8 million remains under its repurchase authorization.
Payoneer reported second-quarter 2024 revenue of $239.5 million, up 16% year-over-year, and raised its 2024 guidance. Net income fell 29% to $32.4 million, which shareholders should weigh against the revenue and adjusted EBITDA gains. The company also acquired Skuad on August 5 for $61 million in cash, plus up to $20 million in contingent payments.
Q2 2024 revenue was $239.5 million, up 16% from $206.7 million a year earlier
Net income was $32.4 million, down 29% from $45.5 million; adjusted EBITDA was $72.8 million, up 30%
2024 revenue guidance is $920 million to $930 million; adjusted EBITDA guidance is $225 million to $235 million
Skuad was acquired on August 5 for $61 million cash, subject to adjustments, plus up to $20 million in contingent payments
Vishay Intertechnology reported fiscal second-quarter 2024 revenue of $741.2 million, roughly flat from the prior quarter but down from $892.1 million a year earlier, and diluted EPS of $0.17 versus $0.68 a year earlier. Management said the industry recovery is taking longer than expected and guided third-quarter revenue to $745 million plus or minus $20 million, with gross margin of 21.0% plus or minus 50 basis points.
Q2 2024 revenue $741.2 million, versus $746.3 million in Q1 2024 and $892.1 million in Q2 2023; gross margin 22.0%, versus 28.9% a year earlier
Q2 2024 EPS $0.17, versus $0.22 in Q1 2024 and $0.68 in Q2 2023; quarterly free cash was negative $86.8 million
Q3 2024 outlook: revenue $745 million plus or minus $20 million; gross margin 21.0% plus or minus 50 basis points, including a 175 to 200 basis point drag from Newport
Itzehoe, Germany expansion timetable moved beyond 2024; 2024 capex now planned at $360 million to $390 million
Extreme Networks reported fourth-quarter fiscal 2024 revenue of $256.7 million, down 29% from a year earlier, and a GAAP loss of $0.42 per share, compared with GAAP diluted earnings of $0.19 a year earlier. The company recorded a $46.5 million provision for excess and obsolete inventory and loss on supplier commitments in the quarter, and guided fiscal first-quarter 2025 revenue to $255.0 million to $265.0 million.
Fiscal Q4 2024 revenue $256.7 million, down 29% year over year; GAAP gross margin 44.7%, compared with 58.9% a year earlier
Fiscal year 2024 revenue $1,117.2 million, down 15%; GAAP loss of $0.65 per share versus diluted EPS of $0.58 in fiscal 2023
Excess and obsolete inventory and supplier commitment charge of $46.5 million in Q4 and $64.5 million for fiscal 2024; non-GAAP diluted EPS for fiscal 2024 was $0.32
Fiscal Q1 2025 guidance: revenue $255.0 million to $265.0 million; full fiscal 2025 revenue guidance $1,110.0 million to $1,135.0 million
Diebold Nixdorf reported second-quarter 2024 revenue of $939.7 million, up 1.9% from a year earlier, and GAAP operating profit of $70.7 million, compared with a loss of $3.9 million in the prior-year quarter. The company raised its full-year adjusted EBITDA guidance to $435 million-$450 million from $410 million-$435 million, but cut its full-year revenue outlook to flat from low single-digit growth, so shareholders get a mixed picture.
Q2 2024 GAAP net income was $14.8 million, versus a net loss of $677.3 million a year earlier, which included reorganization items.
Q2 2024 adjusted EBITDA was $118.8 million, up 40.9% from $84.3 million in the prior-year quarter.
Full-year 2024 revenue outlook was changed to flat, from low single-digit growth, citing retail product market headwinds and a modest unfavorable currency impact.
Free cash flow conversion outlook was unchanged at +25%.
Rockwell Automation reported fiscal third-quarter 2024 sales of $2.05 billion, down 8.4% from a year earlier, and diluted EPS of $2.02, down from $3.45. The company lowered its fiscal 2024 guidance, citing customer project delays tied to weaker consumer demand, high interest rates, and policy uncertainty.
Q3 sales were $2,051 million, down 8.4% from $2,239 million; organic sales also fell 8.4%.
Diluted EPS was $2.02 versus $3.45, and adjusted EPS was $2.71, down 10.0%; diluted EPS includes a $0.46 restructuring charge.
Fiscal 2024 diluted EPS guidance was cut to about $8.32 from $8.80-$9.80; adjusted EPS guidance is now about $9.60 versus $10.00-$11.00.
Reported sales growth guidance was cut to about (8.5)% from (6.0)%-(4.0)%; total ARR rose 17%.
Reynolds Consumer Products reported second-quarter 2024 net revenues of $930 million, down from $940 million a year earlier, while net income rose to $97 million from $66 million and EPS reached $0.46 versus $0.32. The company raised its full-year 2024 net revenue, net income, Adjusted EBITDA and EPS guidance and issued third-quarter 2024 guidance, which points to higher expected profit despite slightly lower sales.
Q2 2024 net revenues were $930 million versus $940 million in Q2 2023, with retail net revenues up 1% to $892 million.
Q2 2024 net income was $97 million versus $66 million, and Adjusted EBITDA was $172 million versus $150 million.
Full-year 2024 Adjusted EBITDA guidance was raised to $670 million to $685 million from $660 million to $680 million, and EPS guidance to $1.65 to $1.71 from $1.62 to $1.70.
The board approved a quarterly dividend of $0.23 per share, payable August 30, 2024, and a $50 million term loan prepayment was made after quarter end.
Wolverine World Wide reported second-quarter 2024 revenue of $425.2 million, down 27.8% from $589.1 million a year earlier, and diluted earnings per share of $0.17 versus $0.30. The company raised parts of its full-year 2024 outlook, including diluted EPS of $0.53 to $0.63 (previously $0.43 to $0.63) and ongoing revenue of $1.71 billion to $1.73 billion, while the year-over-year declines reflect divestitures and lower sales.
Q2 2024 diluted EPS was $0.17 versus $0.30 a year earlier, down 43.3%; adjusted diluted EPS was $0.15 versus $0.19.
Ongoing revenue for the quarter was $424.8 million, down 18.4% from $520.8 million; the company cited divestitures of Keds, Wolverine Leathers and Sperry.
Full-year 2024 diluted EPS guidance is $0.53 to $0.63, and ongoing revenue guidance is $1.71 billion to $1.73 billion.
Inventory at quarter end was $297.1 million, down 54.1% from the prior year, and net debt was $666 million.
National Vision reported second-quarter 2024 net revenue from continuing operations of $451.7 million, up 4.6%, but swung to a net loss from continuing operations of $(1.0) million, compared with income of $3.6 million a year earlier. The company revised its fiscal 2024 outlook downward, with CEO Reade Fahs saying sales needed a greater inflection to deliver the originally expected results. For shareholders, the lower guidance and new transformation actions signal that the company expects slower progress than previously planned.
Q2 2024 net revenue from continuing operations rose 4.6% to $451.7 million; diluted EPS from continuing operations was $(0.01), versus $0.05 a year earlier
Q2 2024 Adjusted Operating Income rose 13.8% to $14.1 million; Adjusted Diluted EPS was $0.15 versus $0.12
Updated fiscal 2024 outlook (as of August 7, 2024) lowers net revenue to $1.820 billion to $1.840 billion and Adjusted Operating Income to $57 million to $62 million, versus prior continuing-operations ranges of $1.825 billion to $1.865 bil
Company is reviewing all stores to optimize its fleet; Alex Wilkes to become President effective August 19, 2024
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.